Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

Clinical trial NCT00788684 · COMPLETED

Trial details

NCT number: NCT00788684
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

CD20-Positive Lymphoid Malignancies Chronic Lymphoid Leukemia Hematological Malignancies Non-Hodgkin's Lymphoma

Start date: 2009-07-21
Primary completion: 2025-02-07
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.